Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK, PD, and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04494243
What this trial is testing

Compare PK, PD and Safety of the AD-214 10/600mg and Rabeprazole

Who this might be right for
Gastroesophageal Reflux Disease
Addpharma Inc. 40
Early research (Phase 1)Study completedNCT07210320
What this trial is testing

PK/PD Study of IN-001 Sublingual Spray in Healthy Adults

Who this might be right for
Food AllergyAnaphylaxisFood Hypersensitivity+1 more
Insignis Therapeutics, Inc. 32
Early research (Phase 1)Study completedNCT01100047
What this trial is testing

Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069

Who this might be right for
Healthy
AstraZeneca 63
Early research (Phase 1)Study completedNCT05337878
What this trial is testing

Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pelacarsen (ISIS 681257) in Healthy Japanese Participants

Who this might be right for
Healthy Participants
Ionis Pharmaceuticals, Inc. 29
Early research (Phase 1)Study completedNCT03976869
What this trial is testing

Assess the Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma

Who this might be right for
Asthma
AstraZeneca 36
Early research (Phase 1)Study completedNCT06025773
What this trial is testing

Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121

Who this might be right for
Gastro Esophageal Reflux
Addpharma Inc. 24
Early research (Phase 1)UnknownNCT03713892
What this trial is testing

CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects

Who this might be right for
Huntington Disease
Chong Kun Dang Pharmaceutical 88
Testing effectiveness (Phase 2)Study completedNCT06713499
What this trial is testing

A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Children and Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 51
Testing effectiveness (Phase 2)Study completedNCT05642507
What this trial is testing

Phase Ib/IIa Trial With AC01 in Patients With HFrEF

Who this might be right for
Heart Failure With Reduced Ejection Fraction
AnaCardio AB 58
Early research (Phase 1)Study completedNCT03294707
What this trial is testing

Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10

Who this might be right for
Amyloid Cardiomyopathy, Transthyretin-Related
Eidos Therapeutics, a BridgeBio company 56
Early research (Phase 1)Study completedNCT03446053
What this trial is testing

Evaluate the Safety, PK, PD, Immunogenicity of N-Rephasin® SAL200 in Healthy Male Volunteers

Who this might be right for
Healthy VolunteersAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus Aureus+1 more
Intron Biotechnology, Inc. 33
Early research (Phase 1)Study completedNCT06553248
What this trial is testing

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes
Gan and Lee Pharmaceuticals, USA 36
Testing effectiveness (Phase 2)Study completedNCT03310021
What this trial is testing

A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

Who this might be right for
Bleeding
Portola Pharmaceuticals 108
Early research (Phase 1)Study completedNCT06508645
What this trial is testing

Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Daewoong Pharmaceutical Co. LTD. 33
Early research (Phase 1)Not Yet RecruitingNCT06916130
What this trial is testing

Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A

Who this might be right for
Gastroesophageal Reflux Disease (GERD)
Addpharma Inc. 48
Early research (Phase 1)Study completedNCT03186677
What this trial is testing

Dose-escalation Study to Investigate the Safety, PK, and PD of ISU304/CB2679d in Hemophilia B Patients

Who this might be right for
Hemophilia B
ISU Abxis Co., Ltd. 11
Testing effectiveness (Phase 2)UnknownNCT02456207
What this trial is testing

A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

Who this might be right for
B-cell Non Hodgkin's Lymphoma
Sinocelltech Ltd. 80
Early research (Phase 1)Study completedNCT03971916
What this trial is testing

A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

Who this might be right for
Healthy Chinese Volunteers
Harbour BioMed (Guangzhou) Co. Ltd. 24
Early research (Phase 1)Looking for participantsNCT06989840
What this trial is testing

Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne

Who this might be right for
Acne
Sagimet Biosciences Inc. 128
Testing effectiveness (Phase 2)Study completedNCT01743768
What this trial is testing

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Who this might be right for
Asthma
Sterna Biologicals GmbH & Co. KG 38
Next Page